
Christopher M. Polley
Examiner (ID: 17176, Phone: (571)270-5734 , Office: P/1785 )
| Most Active Art Unit | 1785 |
| Art Unit(s) | 1785 |
| Total Applications | 782 |
| Issued Applications | 530 |
| Pending Applications | 72 |
| Abandoned Applications | 201 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13734003
[patent_doc_number] => 20180371469
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => EXPRESSION CONSTRUCTS AND METHODS OF GENETICALLY ENGINEERING METHYLOTROPHIC YEAST
[patent_app_type] => utility
[patent_app_number] => 16/123121
[patent_app_country] => US
[patent_app_date] => 2018-09-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13448
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16123121
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/123121 | Expression constructs and methods of genetically engineering methylotrophic yeast | Sep 5, 2018 | Issued |
Array
(
[id] => 18084310
[patent_doc_number] => 11534417
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-12-27
[patent_title] => Enhanced expression of RNA vectors
[patent_app_type] => utility
[patent_app_number] => 16/122376
[patent_app_country] => US
[patent_app_date] => 2018-09-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 15
[patent_no_of_words] => 12408
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 90
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16122376
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/122376 | Enhanced expression of RNA vectors | Sep 4, 2018 | Issued |
Array
(
[id] => 17875742
[patent_doc_number] => 11447745
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-09-20
[patent_title] => End-to-end cell therapy automation
[patent_app_type] => utility
[patent_app_number] => 16/119618
[patent_app_country] => US
[patent_app_date] => 2018-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 60
[patent_no_of_words] => 32338
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 167
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16119618
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/119618 | End-to-end cell therapy automation | Aug 30, 2018 | Issued |
Array
(
[id] => 18399462
[patent_doc_number] => 11661589
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-05-30
[patent_title] => Compositions and methods for controlling microbial growth
[patent_app_type] => utility
[patent_app_number] => 16/113671
[patent_app_country] => US
[patent_app_date] => 2018-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 25
[patent_no_of_words] => 16754
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 170
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16113671
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/113671 | Compositions and methods for controlling microbial growth | Aug 26, 2018 | Issued |
Array
(
[id] => 13958453
[patent_doc_number] => 20190055570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-02-21
[patent_title] => E. coli Separatome-Based Protein Expression And Purification Platform
[patent_app_type] => utility
[patent_app_number] => 16/113840
[patent_app_country] => US
[patent_app_date] => 2018-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 323
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16113840
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/113840 | E. coli Separatome-Based Protein Expression And Purification Platform | Aug 26, 2018 | Abandoned |
Array
(
[id] => 14343111
[patent_doc_number] => 20190153528
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-23
[patent_title] => METHOD FOR TARGET SPECIFIC RNA TRANSCRIPTION OF DNA SEQUENCES
[patent_app_type] => utility
[patent_app_number] => 16/101083
[patent_app_country] => US
[patent_app_date] => 2018-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37559
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16101083
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/101083 | Method for target specific RNA transcription of DNA sequences | Aug 9, 2018 | Issued |
Array
(
[id] => 14639419
[patent_doc_number] => 10364442
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-30
[patent_title] => CRISPR enabled multiplexed genome engineering
[patent_app_type] => utility
[patent_app_number] => 16/056310
[patent_app_country] => US
[patent_app_date] => 2018-08-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 25
[patent_no_of_words] => 9498
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 184
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16056310
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/056310 | CRISPR enabled multiplexed genome engineering | Aug 5, 2018 | Issued |
Array
(
[id] => 13607501
[patent_doc_number] => 20180355300
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-13
[patent_title] => MULTILAYERED CELL CULTURE APPARATUS
[patent_app_type] => utility
[patent_app_number] => 16/054270
[patent_app_country] => US
[patent_app_date] => 2018-08-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7316
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -7
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16054270
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/054270 | MULTILAYERED CELL CULTURE APPARATUS | Aug 2, 2018 | Abandoned |
Array
(
[id] => 15436283
[patent_doc_number] => 20200032325
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-30
[patent_title] => SPECIFIC DETECTION OF DEOXYRIBONUCLEIC ACID SEQUENCES USING NOVEL CRISPR ENZYME-MEDIATED DETECTION STRATEGIES
[patent_app_type] => utility
[patent_app_number] => 16/049460
[patent_app_country] => US
[patent_app_date] => 2018-07-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13896
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 100
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16049460
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/049460 | Specific detection of deoxyribonucleic acid sequences using novel CRISPR enzyme-mediated detection strategies | Jul 29, 2018 | Issued |
Array
(
[id] => 14581987
[patent_doc_number] => 20190218602
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-18
[patent_title] => NOVEL CRISPR ENZYMES AND SYSTEMS
[patent_app_type] => utility
[patent_app_number] => 16/048038
[patent_app_country] => US
[patent_app_date] => 2018-07-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 207313
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16048038
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/048038 | CRISPR enzymes and systems | Jul 26, 2018 | Issued |
Array
(
[id] => 17997855
[patent_doc_number] => 11498949
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-11-15
[patent_title] => System and method for high-yield transient expression in mammalian cells
[patent_app_type] => utility
[patent_app_number] => 16/046641
[patent_app_country] => US
[patent_app_date] => 2018-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 8
[patent_no_of_words] => 33147
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 60
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16046641
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/046641 | System and method for high-yield transient expression in mammalian cells | Jul 25, 2018 | Issued |
Array
(
[id] => 17351708
[patent_doc_number] => 11226339
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-18
[patent_title] => Methods for high throughput receptor:ligand identification
[patent_app_type] => utility
[patent_app_number] => 16/044608
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 49
[patent_no_of_words] => 19724
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16044608
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/044608 | Methods for high throughput receptor:ligand identification | Jul 24, 2018 | Issued |
Array
(
[id] => 14072315
[patent_doc_number] => 20190085045
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-03-21
[patent_title] => METHODS OF PRODUCING TWO CHAIN PROTEINS IN BACTERIA
[patent_app_type] => utility
[patent_app_number] => 16/045517
[patent_app_country] => US
[patent_app_date] => 2018-07-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40721
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16045517
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/045517 | Methods of producing two chain proteins in bacteria | Jul 24, 2018 | Issued |
Array
(
[id] => 17228952
[patent_doc_number] => 20210355508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-11-18
[patent_title] => Method for Modulating RNA Splicing by Inducing Base Mutation at Splice Site or Base Substitution in Polypyrimidine Region
[patent_app_type] => utility
[patent_app_number] => 16/982017
[patent_app_country] => US
[patent_app_date] => 2018-07-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16923
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16982017
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/982017 | Method for Modulating RNA Splicing by Inducing Base Mutation at Splice Site or Base Substitution in Polypyrimidine Region | Jul 23, 2018 | Pending |
Array
(
[id] => 13552509
[patent_doc_number] => 20180327802
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => SEPARATOME-BASED PROTEIN EXPRESSION AND PURIFICATION PLATFORM
[patent_app_type] => utility
[patent_app_number] => 16/040000
[patent_app_country] => US
[patent_app_date] => 2018-07-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24103
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 256
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16040000
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/040000 | SEPARATOME-BASED PROTEIN EXPRESSION AND PURIFICATION PLATFORM | Jul 18, 2018 | Abandoned |
Array
(
[id] => 14261701
[patent_doc_number] => 10280403
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-07
[patent_title] => Host cells with artificial endosymbionts
[patent_app_type] => utility
[patent_app_number] => 16/033679
[patent_app_country] => US
[patent_app_date] => 2018-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 7752
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16033679
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/033679 | Host cells with artificial endosymbionts | Jul 11, 2018 | Issued |
Array
(
[id] => 17421506
[patent_doc_number] => 11254951
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-02-22
[patent_title] => Artificial nucleic acid molecules
[patent_app_type] => utility
[patent_app_number] => 16/030018
[patent_app_country] => US
[patent_app_date] => 2018-07-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 39401
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16030018
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/030018 | Artificial nucleic acid molecules | Jul 8, 2018 | Issued |
Array
(
[id] => 20226360
[patent_doc_number] => 12415000
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-09-16
[patent_title] => CRISPR system based antiviral therapy
[patent_app_type] => utility
[patent_app_number] => 16/629310
[patent_app_country] => US
[patent_app_date] => 2018-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 80674
[patent_no_of_claims] => 51
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16629310
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/629310 | CRISPR system based antiviral therapy | Jul 5, 2018 | Issued |
Array
(
[id] => 13793955
[patent_doc_number] => 20190010516
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-10
[patent_title] => METHOD AND SYSTEM FOR INCORPORATION OF BIOMOLECULES INTO VESICLES, CELLS, AND MICELLES USING ELECTROACTIVE POROUS DEVICE MEMBRANE
[patent_app_type] => utility
[patent_app_number] => 16/026709
[patent_app_country] => US
[patent_app_date] => 2018-07-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8675
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16026709
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/026709 | Method and system for incorporation of biomolecules into vesicles, cells, and micelles using electroactive porous device membrane | Jul 2, 2018 | Issued |
Array
(
[id] => 16824597
[patent_doc_number] => 20210139890
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-13
[patent_title] => NOVEL CRISPR RNA TARGETING ENZYMES AND SYSTEMS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/626932
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48416
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -78
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16626932
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/626932 | NOVEL CRISPR RNA TARGETING ENZYMES AND SYSTEMS AND USES THEREOF | Jul 1, 2018 | Pending |